Search results
Results from the WOW.Com Content Network
However, loss of olfaction is not unique to COVID-19; approximately 13% of patients with influenza also lose olfaction, as do patients with MERS-CoV and Ebola virus. [11] Among the patients with COVID-19, 50% of patients recover olfaction within 14 days, and 89% of patients have complete resolution of their loss of olfaction within 4 weeks.
You may have read about it recently as one of the lingering effects of the COVID-19 virus. One study found that 22% of people who had COVID-19 showed cognitive impairment, such as brain fog, three ...
For premium support please call: 800-290-4726 more ways to reach us
Lighter Side. Medicare. new
ongoing symptomatic COVID-19 for effects from four to twelve weeks after onset, and; post-COVID-19 syndrome for effects that persist 12 or more weeks after onset. The clinical case definitions specify symptom onset and development. For instance, the WHO definition indicates that "symptoms might be new onset following initial recovery or persist ...
In March 2022, the BBC wrote, "There are now many drugs that target the virus or our body in different ways: anti-inflammatory drugs that stop our immune system overreacting with deadly consequences, anti-viral drugs that make it harder for the coronavirus to replicate inside the body and antibody therapies that mimic our own immune system to ...
The coronavirus can damage the heart, according to a major new study which found abnormalities in the heart function of more than half of patients.
Patients with COVID-19 can present with neurological symptoms that can be broadly divided into central nervous system involvement, such as headache, dizziness, altered mental state, and disorientation, and peripheral nervous system involvement, such as anosmia and dysgeusia. [53]